Boehringer Ingelheim (Canada) Ltd./Ltée., a subsidiary of the global pharmaceutical giant Boehringer Ingelheim, is headquartered in Canada and operates extensively across the country. Founded in 1885, the company has established itself as a leader in the pharmaceutical industry, focusing on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. With a commitment to innovation, Boehringer Ingelheim offers a diverse range of core products and services, including prescription medications and vaccines that address critical health challenges. The company is renowned for its research-driven approach, which has led to significant advancements in therapeutic areas such as respiratory diseases, oncology, and diabetes care. Boehringer Ingelheim's strong market position is underscored by its dedication to improving patient outcomes and its notable achievements in developing unique therapies that enhance quality of life. As a trusted name in healthcare, the company continues to make impactful contributions to both human and animal health sectors.
We don't have data for Boehringer Ingelheim (Canada) Ltd./Ltée., but we can show you information about their parent organization instead.
View parent company